These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine. de Whalley PC; Snape MD; Kelly DF; Banner C; Lewis S; Diggle L; John TM; Yu LM; Omar O; Borkowski A; Pollard AJ Pediatr Infect Dis J; 2011 Nov; 30(11):e203-8. PubMed ID: 21673612 [TBL] [Abstract][Full Text] [Related]
26. Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines. Moeller TD; Weyant KB; DeLisa MP Adv Biochem Eng Biotechnol; 2021; 175():355-378. PubMed ID: 30143807 [TBL] [Abstract][Full Text] [Related]
27. Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccines. Javed ; Mandal PK Carbohydr Res; 2021 Apr; 502():108277. PubMed ID: 33743443 [TBL] [Abstract][Full Text] [Related]
28. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation. Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283 [TBL] [Abstract][Full Text] [Related]
29. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395 [TBL] [Abstract][Full Text] [Related]
30. [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines]. Mulard L Ann Pharm Fr; 2007 Jan; 65(1):14-32. PubMed ID: 17299349 [TBL] [Abstract][Full Text] [Related]
31. Glycoengineered Outer Membrane Vesicles as a Platform for Vaccine Development. Valguarnera E; Feldman MF Methods Enzymol; 2017; 597():285-310. PubMed ID: 28935107 [TBL] [Abstract][Full Text] [Related]
32. Revised structures for the capsular polysaccharides from Staphylococcus aureus Types 5 and 8, components of novel glycoconjugate vaccines. Jones C Carbohydr Res; 2005 May; 340(6):1097-106. PubMed ID: 15797125 [TBL] [Abstract][Full Text] [Related]
33. Preclinical studies on new proteins as carrier for glycoconjugate vaccines. Tontini M; Romano MR; Proietti D; Balducci E; Micoli F; Balocchi C; Santini L; Masignani V; Berti F; Costantino P Vaccine; 2016 Jul; 34(35):4235-4242. PubMed ID: 27317455 [TBL] [Abstract][Full Text] [Related]
34. The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine. Donadei A; Balocchi C; Mancini F; Proietti D; Gallorini S; O'Hagan DT; D'Oro U; Berti F; Baudner BC; Adamo R Eur J Pharm Biopharm; 2016 Oct; 107():110-9. PubMed ID: 27388628 [TBL] [Abstract][Full Text] [Related]
35. Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach. Seeberger PH Chem Rev; 2021 Apr; 121(7):3598-3626. PubMed ID: 33794090 [TBL] [Abstract][Full Text] [Related]
36. Semisynthetic glycoconjugate based on dual role protein/PsaA as a pneumococcal vaccine. Prasanna M; Soulard D; Camberlein E; Ruffier N; Lambert A; Trottein F; Csaba N; Grandjean C Eur J Pharm Sci; 2019 Mar; 129():31-41. PubMed ID: 30572107 [TBL] [Abstract][Full Text] [Related]
37. Semisynthetic glycoconjugate vaccine candidate against Lisboa MP; Khan N; Martin C; Xu FF; Reppe K; Geissner A; Govindan S; Witzenrath M; Pereira CL; Seeberger PH Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11063-11068. PubMed ID: 28973947 [TBL] [Abstract][Full Text] [Related]
38. Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance. Del Bino L; Østerlid KE; Wu DY; Nonne F; Romano MR; Codée J; Adamo R Chem Rev; 2022 Oct; 122(20):15672-15716. PubMed ID: 35608633 [TBL] [Abstract][Full Text] [Related]